Chronic Disease Fund Integrity Agreement

Thank you for reading this post, don't forget to subscribe!

Chronic Disease Fund Integrity Agreement: An Overview

The Chronic Disease Fund (CDF) is a non-profit organization that provides financial assistance to low-income individuals suffering from chronic diseases such as cancer, multiple sclerosis, and rheumatoid arthritis. CDF has been under scrutiny in recent years due to allegations of inappropriate relationships with the pharmaceutical industry, resulting in a multi-million dollar settlement agreement with the United States Department of Justice (DOJ) in 2018.

This settlement agreement, known as the Chronic Disease Fund Integrity Agreement (CDFIA), imposed certain requirements and obligations on CDF to ensure compliance with federal and state healthcare laws. The CDFIA requires CDF to implement specific policies and procedures to prevent illegal activities, including kickbacks, fraudulent billing practices, and false claims.

One of the primary obligations under the CDFIA is the requirement to conduct an independent review of all CDF donations and grants received from pharmaceutical manufacturers. These reviews must be conducted by an independent auditor and must be submitted to the DOJ annually for review.

Additionally, CDF must implement a compliance program to prevent and detect healthcare fraud and abuse. This program must include education and training for all employees, volunteers, and board members on healthcare laws and regulations, as well as a system for reporting suspected violations.

CDF is also required to implement a process for reviewing and resolving complaints and concerns from donors, patients, and the public. This process must include an internal investigation of all complaints and concerns, as well as reporting to the DOJ any potential violations of the law.

The CDFIA is a significant step towards ensuring integrity and transparency in the operations of the Chronic Disease Fund. By implementing a compliance program and independent reviews of donations and grants, CDF is taking steps to prevent illegal activities and ensure that donations are used for their intended purpose of providing financial assistance to low-income individuals suffering from chronic diseases.

In conclusion, the Chronic Disease Fund Integrity Agreement is an essential tool for ensuring that non-profit organizations operating in the healthcare industry uphold the highest standards of integrity and transparency. By implementing the requirements set forth in the CDFIA, CDF is taking important steps towards preventing illegal activities and protecting the interests of patients and donors.